404 related articles for article (PubMed ID: 28606749)
1. Cardiovascular disease in systemic lupus erythematosus: A comprehensive update.
Giannelou M; Mavragani CP
J Autoimmun; 2017 Aug; 82():1-12. PubMed ID: 28606749
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease in systemic lupus erythematosus: an update.
Liu Y; Kaplan MJ
Curr Opin Rheumatol; 2018 Sep; 30(5):441-448. PubMed ID: 29870498
[TBL] [Abstract][Full Text] [Related]
3. [Atherosclerosis in systemic lupus erythematosus].
Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus.
Oliveira CB; Kaplan MJ
Semin Immunopathol; 2022 May; 44(3):309-324. PubMed ID: 35355124
[TBL] [Abstract][Full Text] [Related]
5. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
Narshi CB; Giles IP; Rahman A
Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
[TBL] [Abstract][Full Text] [Related]
6. Autoimmunity, oxidized LDL and cardiovascular disease.
Frostegård J
Autoimmun Rev; 2002 Aug; 1(4):233-7. PubMed ID: 12849001
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemia in systemic lupus erythematosus.
Szabó MZ; Szodoray P; Kiss E
Immunol Res; 2017 Apr; 65(2):543-550. PubMed ID: 28168401
[TBL] [Abstract][Full Text] [Related]
8. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.
Gustafsson JT; Svenungsson E
Autoimmunity; 2014 Mar; 47(2):67-76. PubMed ID: 24228980
[TBL] [Abstract][Full Text] [Related]
9. IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.
Ding X; Xiang W; He X
Front Immunol; 2020; 11():581385. PubMed ID: 33262760
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis in Systemic Lupus Erythematosus.
Tobin R; Patel N; Tobb K; Weber B; Mehta PK; Isiadinso I
Curr Atheroscler Rep; 2023 Nov; 25(11):819-827. PubMed ID: 37768411
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis in systemic lupus erythematosus.
Croca S; Rahman A
Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):364-372. PubMed ID: 29224678
[TBL] [Abstract][Full Text] [Related]
12. Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus.
McMahon M; Grossman J; Skaggs B; Fitzgerald J; Sahakian L; Ragavendra N; Charles-Schoeman C; Watson K; Wong WK; Volkmann E; Chen W; Gorn A; Karpouzas G; Weisman M; Wallace DJ; Hahn BH
Arthritis Rheum; 2009 Aug; 60(8):2428-37. PubMed ID: 19644959
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index.
Palmieri V; Migliaresi P; Orefice M; Lupo T; Di Minno MN; Valentini G; Celentano A
Nutr Metab Cardiovasc Dis; 2009 May; 19(4):234-40. PubMed ID: 19157818
[TBL] [Abstract][Full Text] [Related]
14. Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.
Reiss AB; Jacob B; Ahmed S; Carsons SE; DeLeon J
Inflammation; 2021 Oct; 44(5):1663-1682. PubMed ID: 33821395
[TBL] [Abstract][Full Text] [Related]
15. Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.
Somers EC; Zhao W; Lewis EE; Wang L; Wing JJ; Sundaram B; Kazerooni EA; McCune WJ; Kaplan MJ
PLoS One; 2012; 7(5):e37000. PubMed ID: 22606325
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.
Liu Y; Yu X; Zhang W; Zhang X; Wang M; Ji F
J Autoimmun; 2022 Oct; 132():102863. PubMed ID: 35853760
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review.
Schoenfeld SR; Kasturi S; Costenbader KH
Semin Arthritis Rheum; 2013 Aug; 43(1):77-95. PubMed ID: 23422269
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention.
Kostopoulou M; Nikolopoulos D; Parodis I; Bertsias G
Curr Vasc Pharmacol; 2020; 18(6):549-565. PubMed ID: 31880245
[TBL] [Abstract][Full Text] [Related]
19. [High cardiovascular complications in systemic lupus erythematosus: physiopathology and risk management].
Boffa JJ; Rougier JP; Noël N; Ronco P
Nephrol Ther; 2009 Dec; 5(7):595-602. PubMed ID: 19733524
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoprotein functionality in systemic lupus erythematosus.
Ganjali S; Shirmohammadi L; Read MI; Sahebkar A
Semin Arthritis Rheum; 2020 Aug; 50(4):769-775. PubMed ID: 32531506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
